Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Comparison of Institutional Guidelines with Established Early Onset Sepsis Risk Calculator in Reducing Antibiotic Use in an Inner-City NICU in US.

Benaim EH, Upadhyay K, Talati AJ.

J Glob Antimicrob Resist. 2020 Mar 29. pii: S2213-7165(20)30079-5. doi: 10.1016/j.jgar.2020.03.015. [Epub ahead of print]

PMID:
32234556
2.

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer.

Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, Frank JG, Kim DJ, George C, Lee YB, Benaim E, Gittleman B, Hartman SJ, Tan AC, Kim J, Pitts TM, Eckhardt SG, Tentler JJ, Diamond JR.

Mol Cancer Ther. 2019 Nov;18(11):1916-1925. doi: 10.1158/1535-7163.MCT-18-1334. Epub 2019 Sep 5.

PMID:
31488700
3.

RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment.

Balboni B, El Hassouni B, Honeywell RJ, Sarkisjan D, Giovannetti E, Poore J, Heaton C, Peterson C, Benaim E, Lee YB, Kim DJ, Peters GJ.

Expert Opin Investig Drugs. 2019 Apr;28(4):311-322. doi: 10.1080/13543784.2019.1583742. Epub 2019 Mar 16. Review.

PMID:
30879349
4.

Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Kelly KR, Shea TC, Goy A, Berdeja JG, Reeder CB, McDonagh KT, Zhou X, Danaee H, Liu H, Ecsedy JA, Niu H, Benaim E, Iyer SP.

Invest New Drugs. 2014 Jun;32(3):489-99. doi: 10.1007/s10637-013-0050-9. Epub 2013 Dec 20.

5.

Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate cancer diagnosis.

Svatek RS, Shulman MJ, Benaim EA, Rogers TE, Margulis V.

J Urol. 2008 Jun;179(6):2192-5; discussion 2195-6. doi: 10.1016/j.juro.2008.01.142. Epub 2008 Apr 18.

PMID:
18423746
6.
7.

Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens.

Svatek RS, Karam JA, Rogers TE, Shulman MJ, Margulis V, Benaim EA.

Prostate Cancer Prostatic Dis. 2007;10(3):279-82. Epub 2007 Feb 27.

PMID:
17325718
8.

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.

Karam JA, Fan J, Stanfield J, Richer E, Benaim EA, Frenkel E, Antich P, Sagalowsky AI, Mason RP, Hsieh JT.

Int J Cancer. 2007 Apr 15;120(8):1795-802.

9.

Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.

Chen X, Hale GA, Barfield R, Benaim E, Leung WH, Knowles J, Horwitz EM, Woodard P, Kasow K, Yusuf U, Behm FG, Hayden RT, Shurtleff SA, Turner V, Srivastava DK, Handgretinger R.

Br J Haematol. 2006 Nov;135(4):524-32. Epub 2006 Sep 28.

PMID:
17010105
10.

Contemporary techniques and safety of cardiovascular procedures in the surgical management of renal cell carcinoma with tumor thrombus.

Lubahn JG, Sagalowsky AI, Rosenbaum DH, Dikmen E, Bhojani RA, Paul MC, Dolmatch BL, Josephs SC, Benaim EA, Levinson BS, Wait MA, Ring WS, DiMaio JM.

J Thorac Cardiovasc Surg. 2006 Jun;131(6):1289-95.

11.

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

Yusuf U, Hale GA, Carr J, Gu Z, Benaim E, Woodard P, Kasow KA, Horwitz EM, Leung W, Srivastava DK, Handgretinger R, Hayden RT.

Transplantation. 2006 May 27;81(10):1398-404.

PMID:
16732176
12.

Critical analysis of prostate-specific antigen doubling time calculation methodology.

Svatek RS, Shulman M, Choudhary PK, Benaim E.

Cancer. 2006 Mar 1;106(5):1047-53.

13.

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.

Svatek R, Karakiewicz PI, Shulman M, Karam J, Perrotte P, Benaim E.

Eur Urol. 2006 Apr;49(4):666-74. Epub 2006 Jan 6.

PMID:
16423446
14.

Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.

Hale GA, Bowman LC, Rochester RJ, Benaim E, Heslop HE, Krance RA, Horwitz EM, Cunningham JM, Tong X, Srivastava DK, Handgretinger R, Jones DP.

Biol Blood Marrow Transplant. 2005 Nov;11(11):912-20.

15.
16.

Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients.

Chen X, Barfield R, Benaim E, Leung W, Knowles J, Lawrence D, Otto M, Shurtleff SA, Neale GA, Behm FG, Turner V, Handgretinger R.

Blood. 2005 Jan 15;105(2):886-93. Epub 2004 Sep 9.

PMID:
15358630
17.

The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate.

Benaim EA, Karam JA, Soboorian MH, Roehrborn CG, McConnell JD, Lin V.

Prostate. 2004 Sep 1;60(4):310-6.

PMID:
15264242
18.

The natural history of androgen independent prostate cancer.

Shulman MJ, Benaim EA.

J Urol. 2004 Jul;172(1):141-5.

PMID:
15201755
19.

Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis.

Woodard P, Helton K, McDaniel H, Khan RB, Thompson S, Hale G, Benaim E, Kasow K, Leung W, Horwitz E, Srivastava DK, Tong X, Yusuf U, Cunningham JM, Handgretinger R.

Bone Marrow Transplant. 2004 Jun;33(11):1151-7.

21.

Impact of training level of urology residents on the detection of prostate cancer on TRUS biopsy.

Karam JA, Shulman MJ, Benaim EA.

Prostate Cancer Prostatic Dis. 2004;7(1):38-40.

PMID:
14999236
22.

Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia.

Woodard P, Cunningham JM, Benaim E, Chen X, Hale G, Horwitz E, Houston J, Kasow K, Leung W, Wang W, Yusuf U, Handgretinger R.

Bone Marrow Transplant. 2004 Feb;33(4):411-8.

PMID:
14676782
23.

Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients.

Woodard P, Tong X, Richardson S, Srivastava DK, Horwitz EM, Benaim E, Geiger T, Hale G, Leung W, Turner V, Yusuf U, Cunningham J, Handgretinger R.

J Pediatr Hematol Oncol. 2003 Dec;25(12):955-9.

PMID:
14663279
24.

Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome.

Hale GA, Rochester RJ, Heslop HE, Krance RA, Gingrich JR, Benaim E, Horwitz EM, Cunningham JM, Tong X, Srivastava DK, Leung WH, Woodard P, Bowman LC, Handgretinger R.

Biol Blood Marrow Transplant. 2003 Nov;9(11):698-705.

25.

T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation.

Lowe EJ, Turner V, Handgretinger R, Horwitz EM, Benaim E, Hale GA, Woodard P, Leung W.

Br J Haematol. 2003 Oct;123(2):323-6.

PMID:
14531915
26.

Molecular imaging in prostate cancer.

Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT.

J Cell Biochem. 2003 Oct 15;90(3):473-83. Review.

PMID:
14523981
27.

Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.

Hale GA, Bowman LC, Woodard JP, Cunningham JM, Benaim E, Horwitz EM, Heslop HE, Krance RA, Leung W, Shearer PD, Handgretinger R.

Bone Marrow Transplant. 2003 Jun;31(11):981-6.

PMID:
12774048
28.

Characterization of prostate size, PSA and endocrine profiles in patients with spinal cord injuries.

Benaim EA, Montoya JD, Saboorian MH, Litwiller S, Roehrborn CG.

Prostate Cancer Prostatic Dis. 1998 Sep;1(5):250-255.

29.

Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL.

Sandlund JT, Bowman L, Heslop HE, Krance R, Mahmoud H, Pui C-, Hale G, Benaim E.

Cytotherapy. 2002;4(3):253-8.

PMID:
12194721
30.

Gleason score predicts androgen independent progression after androgen deprivation therapy.

Benaim EA, Pace CM, Roehrborn CG.

Eur Urol. 2002 Jul;42(1):12-7.

PMID:
12121723
31.

Open lung biopsy in pediatric bone marrow transplant patients.

Hayes-Jordan A, Benaim E, Richardson S, Joglar J, Srivastava DK, Bowman L, Shochat SJ.

J Pediatr Surg. 2002 Mar;37(3):446-52.

PMID:
11877664
32.

T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.

Slobod KS, Benaim E, Woodruff L, Nooner S, Houston J, Holladay M, Lockey T, Hurwitz JL.

Immunol Res. 2001;24(3):289-301. Review.

PMID:
11817326
33.

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer.

Benaim EA, Pace CM, Lam PM, Roehrborn CG.

Urology. 2002 Jan;59(1):73-8.

PMID:
11796285
34.

Effect of extended immunosuppressive drug treatment on B cell vs T cell reconstitution in pediatric bone marrow transplant recipients.

D'Costa S, Slobod KS, Benaim E, Bowman L, Cunningham J, Holladay M, Howlett N, Srivastava DK, Hurwitz JL.

Bone Marrow Transplant. 2001 Sep;28(6):573-80.

35.

Respiratory virus infections in pediatric hematopoietic stem cell transplantation.

Luján-Zilbermann J, Benaim E, Tong X, Srivastava DK, Patrick CC, DeVincenzo JP.

Clin Infect Dis. 2001 Oct 1;33(7):962-8. Epub 2001 Sep 5.

PMID:
11528566
36.

Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome.

Leung W, Pitts N, Burnette K, Cunningham JM, Horwitz EM, Benaim E, Hale G, Woodard P, Pui CH, Bowman LC.

Bone Marrow Transplant. 2001 Apr;27(7):717-22.

37.

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.

Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.

J Clin Oncol. 2001 May 15;19(10):2696-704.

PMID:
11352962
38.

Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.

Woodard P, Wang W, Pitts N, Benaim E, Horwitz E, Cunningham J, Bowman L.

Bone Marrow Transplant. 2001 Mar;27(6):589-92.

39.

Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.

Leung WH, Turner V, Richardson SL, Benaim E, Hale G, Horwitz EM, Woodard P, Bowman LC.

Hum Immunol. 2001 Apr;62(4):399-407.

PMID:
11295473
40.

Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.

Hale GA, Tong X, Benaim E, Cunningham JM, Heslop HE, Horwiz EM, Leung W, Rochester RJ, Shearer PD, Srivastava DK, Woodard JP, Bowman LC.

Bone Marrow Transplant. 2001 Jan;27(2):155-62.

41.

Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts.

Steen RG, Helton KJ, Horwitz EM, Benaim E, Thompson S, Bowman LC, Krance R, Wang WC, Cunningham JM.

Ann Neurol. 2001 Feb;49(2):222-9.

PMID:
11220742
42.
43.

Molecular evidence of ocular Epstein-Barr virus infection.

Slobod KS, Sandlund JT, Spiegel PH, Haik B, Hurwitz JL, Conley ME, Bowman LC, Benaim E, Jenkins JJ, Stocks RM, Gan Y, Sixbey JW.

Clin Infect Dis. 2000 Jul;31(1):184-8.

PMID:
10913420
44.

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.

Heslop HE, Perez M, Benaim E, Rochester R, Brenner MK, Rooney CM.

J Clin Apher. 1999;14(3):154-6. Review.

PMID:
10540372
45.

Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture.

Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP.

Ann N Y Acad Sci. 1999 Apr 30;872:125-40; discussion 140-1.

PMID:
10372117
47.

Primary central nervous system lymphoma in a child with acute B-cell lymphoblastic leukaemia: consecutive Epstein-Barr virus-related malignancies.

Buckingham SC, Benaim E, Sandlund JT, Gan YJ, Freiden PJ, Behm FG, Ribeiro RC, Sixbey JW, Slobod KS.

Br J Haematol. 1998 May;101(2):345-8.

PMID:
9609533
48.

A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs.

Galipeau J, Benaim E, Spencer HT, Blakley RL, Sorrentino BP.

Hum Gene Ther. 1997 Oct 10;8(15):1773-83.

PMID:
9358027
49.

Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.

Rivera GK, Hudson MM, Liu Q, Benaim E, Ribeiro RC, Crist WM, Pui CH.

Blood. 1996 Aug 1;88(3):831-7.

PMID:
8704238
50.

Gene therapy in pediatric oncology.

Benaim E, Sorrentino BP.

Invest New Drugs. 1996;14(1):87-99. Review.

PMID:
8880396

Supplemental Content

Loading ...
Support Center